<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[mike huckman Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/mike+huckman.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to mike huckman]]></description>
	<s:counts start="0" returned="20" found="59" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Amgen's D-mab Debate]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F147779-amgen-s-d-mab-debate%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Huckman submits:  Analysts are busy jawboning yesterday morning about the side effect Amgen revealed cropped up in a large, late-stage study of its bone drug known as D-mab for breast cancer patients whose disease has spread to the bones. It's known as osteonecrosis of the jaw, or ONJ,...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Thu, 09 Jul 2009 01:38:02 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/mike+huckman.html"><![CDATA[Mike Huckman]]></category>
		<category domain="http://resources.bnet.com/topic/amgen+inc..html"><![CDATA[Amgen Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/novartis+ag.html"><![CDATA[Novartis AG]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMGN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
		<category domain="tickers">AMGN,NVS</category>
	</item>
	<item>
		<title><![CDATA[Sanofi-Aventis Stock Recovering After Lantus Leak]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F146086-sanofi-aventis-stock-recovering-after-lantus-leak%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Huckman submits:  Shares of Sanofi-Aventis SNY are getting a little investor injection on the back of the emergency release of the Lantus diabetic insulin studies late last Friday. The stock had fallen about 10 percent late last week on rumors that reports were about to be published in...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Mon, 29 Jun 2009 11:26:52 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/mike+huckman.html"><![CDATA[Mike Huckman]]></category>
	</item>
	<item>
		<title><![CDATA[Will New CEO Be Positive for Boston Scientific?]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F145498-will-new-ceo-be-positive-for-boston-scientific%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Huckman submits:  Man, it's gotta hurt when the publicly-traded company you've been leading for years announces you're stepping down and investors pop the champagne corks.  Shares of several of the big medical device makers were participating in yesterday's rally, so it's hard to tell if Boston Scientific...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Fri, 26 Jun 2009 01:27:35 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/mike+huckman.html"><![CDATA[Mike Huckman]]></category>
		<category domain="http://resources.bnet.com/topic/boston+scientific+corp..html"><![CDATA[Boston Scientific Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BSX</category>
		<category domain="tickers">BSX</category>
	</item>
	<item>
		<title><![CDATA[J&J Goes to Cougar Town]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F139250-j-j-goes-to-cougar-town%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Huckman submits:  This fall ABC  is launching a new show with Courtney Cox called "Cougar Town." Courtney was one of my favorite "Friends" stars and cougars are certainly a hot cultural phenomenon. Could cougars be five minutes ago by the time the show premieres? Perhaps. But maybe...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Fri, 22 May 2009 01:49:21 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/mike+huckman.html"><![CDATA[Mike Huckman]]></category>
		<category domain="http://resources.bnet.com/topic/johnson+%2526+johnson.html"><![CDATA[Johnson & Johnson]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
		<category domain="tickers">JNJ</category>
	</item>
	<item>
		<title><![CDATA[Will Intuitive Surgical's Appearance on 'Grey's Anatomy' Boost Sales?]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F138034-will-intuitive-surgical-s-appearance-on-grey-s-anatomy-boost-sales%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Huckman submits:  Product placement in movies and TV shows has become commonplace. Usually it's a casual shot that blends into the scenery, sometimes it's a little more obvious - i.e. the Coke KO cups on the American Idol judges' desk - and occasionally it hits you in the...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Sun, 17 May 2009 12:54:48 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/mike+huckman.html"><![CDATA[Mike Huckman]]></category>
		<category domain="http://resources.bnet.com/topic/the+walt+disney+co..html"><![CDATA[The Walt Disney Co.]]></category>
		<category domain="http://resources.bnet.com/topic/intuitive+surgical+inc..html"><![CDATA[Intuitive Surgical Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ISRG</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DIS</category>
		<category domain="tickers">ISRG,DIS</category>
	</item>
	<item>
		<title><![CDATA[Why Is Eli Lilly's CEO on the Media Offensive?]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F137866-why-is-eli-lilly-s-ceo-on-the-media-offensive%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Huckman submits:  Pfizer PFE Chairman and CEO Jeff Kindler last year repeatedly said big deals in big pharma don't work. But, he added, he'd never say never. And sure enough, this year Kindler's buying Wyeth WYE. But here we have the Chairman and CEO of one of the...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Fri, 15 May 2009 01:34:09 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/mike+huckman.html"><![CDATA[Mike Huckman]]></category>
		<category domain="http://resources.bnet.com/topic/bristol-myers+squibb+co..html"><![CDATA[Bristol-Myers Squibb Co.]]></category>
		<category domain="http://resources.bnet.com/topic/eli+lilly+%2526+co..html"><![CDATA[Eli Lilly & Co.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
		<category domain="tickers">BMY,LLY</category>
	</item>
	<item>
		<title><![CDATA[Novartis Hires an Apprentice CFO]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F137483-novartis-hires-an-apprentice-cfo%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Huckman submits:  What does it say when a drugmaker hires a Goldman Sachs investment banker as its next Chief Financial Officer? That's the question I'm asking after Novartis NVS announced that it's tapped a managing director of investment banking at Goldman Sachs, Jonathan Symonds, as its CFO apprentice....]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Wed, 13 May 2009 09:03:07 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/mike+huckman.html"><![CDATA[Mike Huckman]]></category>
		<category domain="http://resources.bnet.com/topic/novartis+ag.html"><![CDATA[Novartis AG]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
		<category domain="tickers">NVS</category>
	</item>
	<item>
		<title><![CDATA[Amylin: I'm Not Taking Sides]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F136947-amylin-i-m-not-taking-sides%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Huckman submits:  Imagine my surprise when I got an email over the weekend from "Diabetic Investor" newsletter editor David Kliff informing me that Amylin Pharmaceuticals AMLN    is quoting me in a letter to shareholders.       AMLN is engaged in an...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Mon, 11 May 2009 10:05:05 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/mike+huckman.html"><![CDATA[Mike Huckman]]></category>
		<category domain="http://resources.bnet.com/topic/amylin+pharmaceuticals+inc..html"><![CDATA[Amylin Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMLN</category>
		<category domain="tickers">AMLN</category>
	</item>
	<item>
		<title><![CDATA[Will New Results on Merck and GSK's HPV Vaccines Ignite Sales Growth?]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F136704-will-new-results-on-merck-and-gsk-s-hpv-vaccines-ignite-sales-growth%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Huckman submits:  A new study shows that Merck's MRK Gardasil vaccine protects some young women from a strain of a sexually transmitted disease that can lead to cervical cancer for nearly a decade. Up until now, there's only been evidence that the series of three shots for the...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Sun, 10 May 2009 01:23:43 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/mike+huckman.html"><![CDATA[Mike Huckman]]></category>
		<category domain="http://resources.bnet.com/topic/glaxosmithkline+plc..html"><![CDATA[GlaxoSmithKline Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="tickers">GSK,MRK</category>
	</item>
	<item>
		<title><![CDATA[Vanda Snaps Up Victory from the Jaws of Defeat]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F136392-vanda-snaps-up-victory-from-the-jaws-of-defeat%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Huckman submits:  Wednesday, Vanda Pharmaceuticals VNDA had a market value of $28 million. That's way too small to mention on CNBC, here on the blog or even on Twitter. But exceptions can be made when a company, even one that little, has real news. by Mike Huckman]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Fri, 08 May 2009 12:22:10 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/mike+huckman.html"><![CDATA[Mike Huckman]]></category>
		<category domain="http://resources.bnet.com/topic/novartis+ag.html"><![CDATA[Novartis AG]]></category>
		<category domain="http://resources.bnet.com/topic/vanda+pharmaceuticals+inc..html"><![CDATA[Vanda Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">VNDA</category>
		<category domain="tickers">NVS,VNDA</category>
	</item>
	<item>
		<title><![CDATA[Roche and Genentech: Get Your Act Together]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F135967-roche-and-genentech-get-your-act-together%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Huckman submits:  It's a new world. Before Roche (RHHBY.PK) bought Genentech, stock-moving drug development milestones for DNA were closely followed by the news media, analysts and investors. But because the Swiss drugmaker Roche only trades over-the-counter in the U.S., the information isn't as "actionable" as it used to...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Wed, 06 May 2009 11:49:51 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/mike+huckman.html"><![CDATA[Mike Huckman]]></category>
	</item>
	<item>
		<title><![CDATA[Why Did Dendreon Execs Cash Out on Friday?]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F135250-why-did-dendreon-execs-cash-out-on-friday%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Huckman submits:  Whenever a politician, government agency or company puts out news late on a Friday, chances are it probably isn't good or it's stuff they'd like to just slip under the door. That's when they like to dump stuff that will usually get less attention over a...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Tue, 05 May 2009 12:10:41 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/mike+huckman.html"><![CDATA[Mike Huckman]]></category>
		<category domain="http://resources.bnet.com/topic/dendreon+corp..html"><![CDATA[Dendreon Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DNDN</category>
		<category domain="tickers">DNDN</category>
	</item>
	<item>
		<title><![CDATA[The Sequenom Syndrome]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F134311-the-sequenom-syndrome%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Huckman submits:  Shares of San Diego-based Sequenom SQNM are sinking on huge trading volume. The company shocked investors after the closing bell yesterday when it issued this press release announcing that its data couldn't be trusted. by Mike Huckman]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Thu, 30 Apr 2009 09:25:55 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/mike+huckman.html"><![CDATA[Mike Huckman]]></category>
		<category domain="http://resources.bnet.com/topic/sequenom+inc..html"><![CDATA[Sequenom Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SQNM</category>
		<category domain="tickers">SQNM</category>
	</item>
	<item>
		<title><![CDATA[Rare Failure for Roche's Avastin]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F132511-rare-failure-for-roche-s-avastin%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Huckman submits:  It's a good thing I'm working the graveyard shift this month anchoring "Worldwide Exchange" at four o'clock in the morning. It was about the time that I woke up to go to work yesterday at 1 a.m. ET that Roche (RHHBY.PK) and Genentech sent out their...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Thu, 23 Apr 2009 12:14:31 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/mike+huckman.html"><![CDATA[Mike Huckman]]></category>
	</item>
	<item>
		<title><![CDATA[The ABCs of Lilly: Amylin, Byetta & Carl]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F131924-the-abcs-of-lilly-amylin-byetta-carl%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Huckman submits:  Shortly after Eli Lilly LLY reported way better than expected earnings yesterday morning, Amylin Pharmaceuticals  AMLN fired a new salvo in its escalating proxy battle with billionaire activist investor Carl Icahn.  LLY and AMLN are partners on the twice-a-day injectable diabetes drug Byetta, and...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Tue, 21 Apr 2009 12:29:58 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/mike+huckman.html"><![CDATA[Mike Huckman]]></category>
		<category domain="http://resources.bnet.com/topic/amylin+pharmaceuticals+inc..html"><![CDATA[Amylin Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/eli+lilly+%2526+co..html"><![CDATA[Eli Lilly & Co.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMLN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
		<category domain="tickers">AMLN,LLY</category>
	</item>
	<item>
		<title><![CDATA[Biotech Analyst Eats Dendreon's Provenge Crow]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F131259-biotech-analyst-eats-dendreon-s-provenge-crow%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Huckman submits:  As late as the day before the positive Dendreon DNDN data on its prostate cancer treatment Provenge came out, biotech analyst Jonathan Aschoff at Brean Murray Carret & Co. reiterated his "Sell" rating and $1 price target on the stock in a research note to clients....]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Thu, 16 Apr 2009 08:37:32 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/mike+huckman.html"><![CDATA[Mike Huckman]]></category>
		<category domain="http://resources.bnet.com/topic/dendreon+corp..html"><![CDATA[Dendreon Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DNDN</category>
		<category domain="tickers">DNDN</category>
	</item>
	<item>
		<title><![CDATA[Merck / Cardiome: Big Pharma Meets Baby Biotech]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F130231-merck-cardiome-big-pharma-meets-baby-biotech%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Huckman submits:  Victory for vernakalant!   No, that's not German. It's the scientific, generic name of the experimental heart rhythm maintenance drug at a little Canadian company called Cardiome CRME. The announcement came out Wednesday evening that Merck MRK is hooking up with CRME in yet another...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Thu, 09 Apr 2009 08:10:58 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/mike+huckman.html"><![CDATA[Mike Huckman]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="tickers">MRK</category>
	</item>
	<item>
		<title><![CDATA[Dendreon: Freaky Friday]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F129392-dendreon-freaky-friday%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Huckman submits:  I'm not really enjoying my "day off" so far here in rather gloomy, cool L.A. as I've been kept pretty busy trying to chase down the Dendreon DNDN. The shares are hitting a new intra-day high on heavy volume on word that the American Urological Association...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Fri, 03 Apr 2009 12:44:38 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/mike+huckman.html"><![CDATA[Mike Huckman]]></category>
		<category domain="http://resources.bnet.com/topic/dendreon+corp..html"><![CDATA[Dendreon Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DNDN</category>
		<category domain="tickers">DNDN</category>
	</item>
	<item>
		<title><![CDATA[Did Dendreon Play with Fire?]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F127883-did-dendreon-play-with-fire%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Huckman submits:  Oh, the Dendreon DNDN investor message boards are on fire! And my inbox has a few sparks. Matthew Herper at Forbes wrote a piece today daring to question the integrity of the all-important data due out sometime next month on DNDN's prostate cancer treatment Provenge. Interestingly,...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Wed, 25 Mar 2009 01:42:24 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/mike+huckman.html"><![CDATA[Mike Huckman]]></category>
		<category domain="http://resources.bnet.com/topic/dendreon+corp..html"><![CDATA[Dendreon Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DNDN</category>
		<category domain="tickers">DNDN</category>
	</item>
	<item>
		<title><![CDATA[Biopharma, Especially Merck, Having a Good Week]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F125918-biopharma-especially-merck-having-a-good-week%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Huckman submits:  Shares of Dow component Merck MRK are getting a nice little shot in the arm this morning on an upgrade by Dr. Tim Anderson at Sanford C. Bernstein. He's putting an "Outperform" or "Buy" rating on MRK and raising his target price three bucks to $30....]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Fri, 13 Mar 2009 09:07:04 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/mike+huckman.html"><![CDATA[Mike Huckman]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">MRK,PFE</category>
	</item>
</channel>
</rss>
